Release Date: 27/01/23 11:18 Summary: Change of Director's Interest Notice x2 Price Sensitive: No Download Document 388.07KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%